Pharmaceutical Giant Novartis Challenges India’s Patent Laws, Threatening Delivery of AIDS Drugs to Tens of Thousands

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


The pharmaceutical industry once again stirs a witches’ brew, reports New Scientist, challenging patent laws that have enabled India to supply AIDS drugs to poor patients worldwide.

India’s generic drugs form the backbone of MSF’s [Medecins Sans Frontieres/Doctors without Borders] AIDS programmes, in which 80,000 people in 30 countries receive treatment.

“We are reaching a quarter of the people who need antiretroviral treatment in sub-Saharan Africa,” says Ivy Mwangi, an MSF doctor. “Rapid scale-up in treatment is only possible with the availability and affordability of generic drugs, most of which are produced in India.”

But Swiss pharma-giant Novartis is whinging that financial hegemony is the only sure road to drug innovation, and that India should not be allowed to provide generics for people who can’t pay $10,000 a year for its drugs.

“If Novartis gets through with its case our lives are at risk,” Monique Wanjala, a woman who has been living with HIV for 13 years, told a news conference in Nairobi. “We want this case dropped,” she said. “If we die because affordable generic drugs aren’t available, where will they sell the drug? If profits are going to be put before peoples’ lives then we have a serious problem.”

A BETTER WAY TO DO THIS?

We have an ambitious $350,000 online fundraising goal this month and we can't afford to come up short. But when a reader recently asked how being a nonprofit makes Mother Jones different from other news organizations, we realized we needed to lay this out better: Because "in absolutely every way" is essentially the answer.

So we tried to explain why your year-end donations are so essential, and we'd like your help refining our pitch about what make Mother Jones valuable and worth reading to you.

We'd also like your support of our journalism with a year-end donation if you can right now—all online gifts will be doubled until we hit our $350,000 goal thanks to an incredibly generous donor's matching gift pledge.

payment methods

A BETTER WAY TO DO THIS?

We have an ambitious $350,000 online fundraising goal this month and we can't afford to come up short. But when a reader recently asked how being a nonprofit makes Mother Jones different from other news organizations, we realized we needed to lay this out better: Because "in absolutely every way" is essentially the answer.

So we tried to explain why your year-end donations are so essential, and we'd like your help refining our pitch about what make Mother Jones valuable and worth reading to you.

We'd also like your support of our journalism with a year-end donation if you can right now—all online gifts will be doubled until we hit our $350,000 goal thanks to an incredibly generous donor's matching gift pledge.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate